These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 31897617)
1. Resection Plus Post-operative Adjuvant Transcatheter Arterial Chemoembolization (TACE) Compared with Resection Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. Huo YR; Chan MV; Chan C Cardiovasc Intervent Radiol; 2020 Apr; 43(4):572-586. PubMed ID: 31897617 [TBL] [Abstract][Full Text] [Related]
2. Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis. Chen ZH; Zhang XP; Zhou TF; Wang K; Wang H; Chai ZT; Shi J; Guo WX; Cheng SQ Eur J Surg Oncol; 2019 Nov; 45(11):2188-2196. PubMed ID: 31256949 [TBL] [Abstract][Full Text] [Related]
3. Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis. Qi X; Liu L; Wang D; Li H; Su C; Guo X Oncotarget; 2015 Nov; 6(34):36838-59. PubMed ID: 26451613 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion. Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695 [TBL] [Abstract][Full Text] [Related]
5. Transcatheter Arterial Chemoembolization Plus Radiotherapy Compared With Chemoembolization Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. Huo YR; Eslick GD JAMA Oncol; 2015 Sep; 1(6):756-65. PubMed ID: 26182200 [TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma. Liu C; Sun L; Xu J; Zhao Y World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790 [TBL] [Abstract][Full Text] [Related]
7. Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and meta-analysis. Qi X; Wang D; Su C; Li H; Guo X Oncotarget; 2015 Jul; 6(21):18715-33. PubMed ID: 26243835 [TBL] [Abstract][Full Text] [Related]
8. Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus. Peng ZW; Guo RP; Zhang YJ; Lin XJ; Chen MS; Lau WY Cancer; 2012 Oct; 118(19):4725-36. PubMed ID: 22359112 [TBL] [Abstract][Full Text] [Related]
9. Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysis. Liang L; Li C; Diao YK; Jia HD; Xing H; Pawlik TM; Lau WY; Shen F; Huang DS; Zhang CW; Yang T Therap Adv Gastroenterol; 2020; 13():1756284820977693. PubMed ID: 33329759 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of preoperative chemoembolization for resectable hepatocellular carcinoma with portal vein invasion: a prospective comparative study. Zhang YF; Guo RP; Zou RH; Shen JX; Wei W; Li SH; OuYang HY; Zhu HB; Xu L; Lao XM; Shi M Eur Radiol; 2016 Jul; 26(7):2078-88. PubMed ID: 26396105 [TBL] [Abstract][Full Text] [Related]
11. Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety. Wei W; Jian PE; Li SH; Guo ZX; Zhang YF; Ling YH; Lin XJ; Xu L; Shi M; Zheng L; Chen MS; Guo RP Cancer Commun (Lond); 2018 Oct; 38(1):61. PubMed ID: 30305149 [TBL] [Abstract][Full Text] [Related]
12. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study. Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241 [TBL] [Abstract][Full Text] [Related]
13. Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis. Zhang XP; Wang K; Li N; Zhong CQ; Wei XB; Cheng YQ; Gao YZ; Wang H; Cheng SQ BMC Cancer; 2017 Dec; 17(1):902. PubMed ID: 29282010 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus. Peng BG; He Q; Li JP; Zhou F Am J Surg; 2009 Sep; 198(3):313-8. PubMed ID: 19285298 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients with Mesenchymal Circulating Tumor Cell. Zhang J; Peng H; Wang B; Luo L; Cheng Y; He G; Tang Y; Pan M J Gastrointest Surg; 2021 Jul; 25(7):1770-1778. PubMed ID: 32748340 [TBL] [Abstract][Full Text] [Related]
16. Does postoperative adjuvant transarterial chemoembolization benefit for all patients with hepatocellular carcinoma combined with microvascular invasion: a meta-analysis. Wang L; Ke Q; Lin N; Zeng Y; Liu J Scand J Gastroenterol; 2019 May; 54(5):528-537. PubMed ID: 31081401 [No Abstract] [Full Text] [Related]
17. Therapeutic value of transcatheter arterial chemoembolization combined with portal vein embolization for primary hepatocellular carcinoma with portal vein tumor thrombus: a pilot study. Tan X; Xie P; Liu J; Wu H; Xie Y Asia Pac J Clin Oncol; 2015 Sep; 11(3):e6-e12. PubMed ID: 25228074 [TBL] [Abstract][Full Text] [Related]
18. Postoperative adjuvant transcatheter arterial chemoembolization should be considered selectively in patients who have hepatocellular carcinoma with microvascular invasion. Wang YY; Wang LJ; Xu D; Liu M; Wang HW; Wang K; Zhu X; Xing BC HPB (Oxford); 2019 Apr; 21(4):425-433. PubMed ID: 30249510 [TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma. Yang DJ; Luo KL; Liu H; Cai B; Tao GQ; Su XF; Hou XJ; Ye F; Li XY; Tian ZQ Oncotarget; 2017 Jan; 8(2):2960-2970. PubMed ID: 27936465 [TBL] [Abstract][Full Text] [Related]
20. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors]. Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]